drugset / Trial / NCT03977805
Metabolism and Disposition of [14C] Herombopag in Chinese Healthy Human Subjects
NaSingle-groupOpen-labelOther
Summary
This study is a single-center, open-label, single-dose design. It is planning to enroll six Chinese healthy adult male subjects. The metabolism and disposition of Herombopag, will be studied in these subjects after a single oral administration of a solution dose of \[14C\] Herombopag (5 mg, 100 uCi).
Timeline
- Start
- 2019-05-25
- Primary completion
- 2019-06-13
- Completion
- 2019-06-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hetrombopag | Small molecule | 5 mg | Oral |
Indications
No indication recorded.